JPMorgan Chase & Co. Boosts Cabot (NYSE:CBT) Price Target to $78.00

Cabot (NYSE:CBT) had its target price upped by equities research analysts at JPMorgan Chase & Co. from $70.00 to $78.00 in a research report issued on Friday,Benzinga reports. The firm currently has an “underweight” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s price target would indicate a potential downside of 9.44% from the stock’s previous close.

Several other research analysts have also recently issued reports on the company. Mizuho increased their price objective on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. Wall Street Zen lowered shares of Cabot from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Truist Financial set a $100.00 price target on shares of Cabot in a research note on Wednesday. UBS Group cut their price target on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a report on Wednesday. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Cabot presently has an average rating of “Hold” and a consensus price target of $89.00.

Cabot Stock Performance

NYSE CBT traded down $1.42 during trading hours on Friday, hitting $86.13. 69,311 shares of the stock were exchanged, compared to its average volume of 480,132. The company has a quick ratio of 0.96, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The company has a market cap of $4.45 billion, a price-to-earnings ratio of 24.34, a price-to-earnings-growth ratio of 11.03 and a beta of 0.84. Cabot has a 12-month low of $58.33 and a 12-month high of $94.53. The stock has a 50-day moving average of $87.92 and a 200 day moving average of $79.82.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities research analysts forecast that Cabot will post 6.33 earnings per share for the current year.

Institutional Trading of Cabot

Several large investors have recently bought and sold shares of CBT. Public Employees Retirement System of Ohio boosted its position in shares of Cabot by 15.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company’s stock valued at $80,000 after purchasing an additional 160 shares during the period. Janney Montgomery Scott LLC increased its stake in Cabot by 2.6% in the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company’s stock worth $417,000 after purchasing an additional 161 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in Cabot by 9.6% during the 4th quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company’s stock worth $124,000 after buying an additional 164 shares during the period. Parallel Advisors LLC lifted its stake in Cabot by 10.5% during the first quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company’s stock valued at $139,000 after buying an additional 175 shares in the last quarter. Finally, Swiss Life Asset Management Ltd lifted its stake in Cabot by 3.6% during the second quarter. Swiss Life Asset Management Ltd now owns 6,147 shares of the specialty chemicals company’s stock valued at $558,000 after buying an additional 212 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.